Literature DB >> 29631477

Reprogramming p53-Deficient Germline Stem Cells Into Pluripotent State by Nanog.

Yanmin Feng1,2, Yan Ning1,2, Xiwen Lin1, Daoqin Zhang1,2, Shangying Liao1, Chunwei Zheng1,2, Jian Chen1,2, Yang Wang1,2, Longfei Ma1,2, Dan Xie1,2, Chunsheng Han1.   

Abstract

Cultured mouse spermatogonial stem cells (SSCs), also known as germline stem cells (GSCs), revert back to pluripotent state either spontaneously or upon being modified genetically. However, the reprogramming efficiencies are low, and the underlying mechanism remains poorly understood. In the present study, we conducted transcriptomic analysis and found that many transcription factors and epigenetic modifiers were differentially expressed between GSCs and embryonic stem cells. We failed in reprogramming GSCs to pluripotent state using the Yamanaka 4 Factors, but succeeded when Nanog and Tet1 were included. More importantly, reprogramming was also achieved with Nanog alone in a p53-deficient GSC line with an efficiency of 0.02‰. These GSC-derived-induced pluripotent stem cells possessed in vitro and in vivo differentiation abilities despite the low rate of chimera formation, which might be caused by abnormal methylation in certain paternally imprinted genes. Together, these results show that GSCs can be reprogrammed to pluripotent state via multiple avenues and contribute to our understanding of the mechanisms of GSC reprogramming.

Entities:  

Keywords:  Nanog; germline stem cells; pluripotency; reprogramming

Mesh:

Substances:

Year:  2018        PMID: 29631477     DOI: 10.1089/scd.2018.0047

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  1 in total

1.  HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1.

Authors:  Shujuan Shu; Zhi Li; Liu Liu; Xia Ying; Yina Zhang; Ting Wang; Xiaoye Zhou; Peiyue Jiang; Weiguo Lv
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.